The immunopathology of complement proteins and innate immunity in autoimmune disease

F Defendi, NM Thielens, G Clavarino… - Clinical Reviews in …, 2020 - Springer
The complement is a powerful cascade of the innate immunity and also acts as a bridge
between innate and acquired immune defence. Complement activation can occur via three …

Nephritic factors: an overview of classification, diagnostic tools and clinical associations

F Corvillo, M Okrój, P Nozal, M Melgosa… - Frontiers in …, 2019 - frontiersin.org
Nephritic factors comprise a heterogeneous group of autoantibodies against neoepitopes
generated in the C3 and C5 convertases of the complement system, causing its …

Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice

N Knoers, C Antignac, C Bergmann… - Nephrology Dialysis …, 2022 - academic.oup.com
The overall diagnostic yield of massively parallel sequencing–based tests in patients with
chronic kidney disease (CKD) is 30% for paediatric cases and 6–30% for adult cases. These …

[HTML][HTML] Alternative complement pathway inhibition with iptacopan for the treatment of C3 glomerulopathy-study design of the APPEAR-C3G trial

AS Bomback, D Kavanagh, M Vivarelli, M Meier… - Kidney International …, 2022 - Elsevier
Introduction Complement 3 glomerulopathy (C3G) is a rare kidney disease characterized by
dysregulation of the alternative pathway (AP) of the complement system. About 50% of …

[HTML][HTML] Clinical safety and efficacy of pegcetacoplan in a phase 2 study of patients with C3 glomerulopathy and other complement-mediated glomerular diseases

BP Dixon, LA Greenbaum, L Huang, S Rajan… - Kidney International …, 2023 - Elsevier
Introduction Dysregulated complement activation is likely the primary driver of disease in C3
glomerulopathy (C3G) and contributes to other complement-mediated diseases, including …

C5 convertase blockade in membranoproliferative glomerulonephritis: a single-arm clinical trial

P Ruggenenti, E Daina, A Gennarini, C Carrara… - American Journal of …, 2019 - Elsevier
Rationale & Objective Primary membranoproliferative glomerulonephritis (MPGN) is a rare
glomerulopathy characterized by complement dysregulation. MPGN progresses rapidly to …

Clinico-pathogenic similarities and differences between infection-related glomerulonephritis and C3 glomerulopathy

Y Wada, M Kamata, R Miyasaka, T Abe… - International Journal of …, 2023 - mdpi.com
Recently, the comprehensive concept of “infection-related glomerulonephritis (IRGN)” has
replaced that of postinfectious glomerulonephritis (PIGN) because of the diverse infection …

Characteristics of biopeptides released in silico from collagens using quantitative parameters

A Iwaniak, P Minkiewicz, M Pliszka, D Mogut… - Foods, 2020 - mdpi.com
The potential of collagens to release biopeptides was evaluated using the BIOPEP-UWM-
implemented quantitative criteria including the frequency of the release of fragments with a …

Complement catalyzing glomerular diseases

PF Zipfel, T Wiech, HJ Gröne, C Skerka - Cell and Tissue Research, 2021 - Springer
Complement is an evolutionarily conserved system which is important in the defense against
microorganisms and also in the elimination of modified or necrotic elements of the body …

Large-scale whole-genome sequencing reveals the genetic architecture of primary membranoproliferative GN and C3 glomerulopathy

AP Levine, MMY Chan… - Journal of the …, 2020 - journals.lww.com
Background Primary membranoproliferative GN, including complement 3 (C3)
glomerulopathy, is a rare, untreatable kidney disease characterized by glomerular …